If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD patients in managing their symptoms and thus leading normal lives.

Beyond Hype AI, ChatGPT and LLMs Are Practical Tools for Improved Care and Optimized Processes

New Study Points to a Strong Possibility that Digital Health Can Advance Migraine Care Treatment

Cedar Health Research, located in Dallas and Irving, is currently enrolling candidates in two clinical trials to evaluate the safety and tolerability of Rimegepant